Hong Joon Pio, Lee Moo Young, Kim Eun Key, Seo Dong Hwan
Department of Plastic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
J Craniofac Surg. 2009 Jan;20(1):252-4. doi: 10.1097/SCS.0b013e3181843257.
This report presents the treatment of an extensive lymphatic malformation of the tongue. Sclerosing agents are now widely used as the first-line treatment of lymphatic malformation. However, treatment of lymphatic malformation involving the face and the vital structures such as the airway remains to be challenging. A 4-year-old boy underwent a total of 15 OK-432 injection sclerotherapy treatments over a 2-year period, having slow progress until sudden enlargement of the tongue was noted shortly after the last injection. Partial excision of the lesion was performed. This case demonstrates the risk in treating large microcystic lymphatic malformation of the tongue with sclerotherapy and provides an insight in the management protocol.
本报告介绍了一例广泛的舌部淋巴管畸形的治疗情况。硬化剂目前被广泛用作淋巴管畸形的一线治疗方法。然而,涉及面部和气道等重要结构的淋巴管畸形的治疗仍然具有挑战性。一名4岁男孩在两年内共接受了15次OK-432注射硬化治疗,进展缓慢,直到最后一次注射后不久发现舌头突然肿大。对病变进行了部分切除。该病例显示了用硬化疗法治疗巨大微囊性舌部淋巴管畸形的风险,并为治疗方案提供了见解。